Inhibition of acoustic priming in mice

Area of Science:

• Neuroscience
• Pharmacology
• Genetics

Background:

• C57BL/6J mice exhibit susceptibility to audiogenic seizures via acoustic priming.
• This priming process can be inhibited by specific pharmacological agents.

Purpose of the Study:

• To investigate the effects of puromycin and other drugs on acoustic priming-induced audiogenic seizures in mice.
• To explore the potential mechanisms by which puromycin exerts its protective effects.

Main Methods:

• Administration of puromycin, puromycin aminonucleoside, cycloheximide, diphenylhydantoin, and d-amphetamine to C57BL/6J mice.
• Exposure of mice to acoustic priming stimulus.
• Testing for susceptibility to audiogenic seizures and electroconvulsive seizures.

Main Results:

• Puromycin and puromycin aminonucleoside effectively blocked acoustic priming-induced audiogenic seizures.
• Cycloheximide, diphenylhydantoin, and d-amphetamine showed minimal effect on priming-induced seizures.
• Co-administration of other drugs with puromycin reversed its protective action.
• Puromycin increased susceptibility to electroconvulsive seizures in young mice.

Conclusions:

• Puromycin's blockade of audiogenic seizures suggests a role in neurochemical processes.
• Potential mechanisms include disruption of brain electrical activity or interference with peptide-mediated neurohumoral transmission.